The Searle Company Limited (SEARL): Result Review – By Taurus Research
Oct 6 2025
Taurus Securities
- The Company reported a top-line of PKR 28.6Bn, down 3%YoY from PKR 29.4Bn driven by lower volumetric sales. Gross margins improved 3pptsYoY, supported by deregulation of non-essential medicines. Finance costs fell by 42%YoY on the back of lower interest rate and a 99%YoY reduction in long term borrowings. Meanwhile, loss from discontinued operations stood at PKR 2.2Bn, down 36%YoY. As a result, LAT dropped 43%YoY to PKR 1.4Bn, translating into an LPS of PKR 2.73/sh.
- In 4QFY25, top-line clocked in at PKR 6.6Bn, down 7%YoY/6%QoQ. Gross margins increased 2pptsYoY/stable QoQ supported by higher prices for medicines following deregulation. Finance costs dropped 64%YoY/7%QoQ, primarily due to reduction in long term borrowings. The Company posted a LAT of PKR 119Mn from its continuing operations and a loss of PKR 969Mn from discontinued operations, converted into an overall LAT of PKR 1.1BnYoY. Consequently, LPS stood at PKR 2.13/sh. Finally, the Company also announced 15% bonus shares for the year.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low